CCDC32

CCDC32 is an assembly chaperone for the heterotetrameric AP-2 adaptor complex and thereby a regulator of clathrin-mediated endocytosis (PMID:39145939, PMID:38979322, PMID:41489497). It functions in the AP-2 biogenesis pathway downstream of AAGAB, recognizing the AAGAB:α:σ2 intermediate to form an α:σ2:CCDC32 ternary complex that templates sequential recruitment of the µ2 and β2 subunits, after which CCDC32 is released to yield the complete adaptor (PMID:39145939). CCDC32 engages AP-2 through multiple contacts: a predicted α-helix (aa78–98) required for AP-2 binding and endocytic function, the α-appendage domain at sites shared with canonical endocytic regulators plus a novel conserved pocket, and cargo-binding sites engaged via its own cargo sorting motifs (PMID:38979322, PMID:41489497, PMID:40799577, PMID:42234739). Two amphipathic helices bind the α/σ2 heterodimer and actively prevent AP-2 assembly—and disassemble AP-2 tetramers—in solution, an inhibition relieved by PIP2-containing membranes that act as a molecular switch to deposit assembled AP-2 at the plasma membrane; consistent with this role, loss of CCDC32 produces unstable flat clathrin assemblies and impairs coated-pit invagination and transferrin uptake (PMID:33859415, PMID:38979322, PMID:41489497, PMID:40799577, PMID:42234739). CCDC32 is additionally required for normal ciliogenesis, and a disease-causing mutation that disrupts its AP-2 chaperone function underlies the associated congenital syndrome (PMID:32307552, PMID:39145939).

1. 2011 Low

   Before any functional assignment, an unbiased interaction screen offered the first candidate binding partner for the uncharacterized CCDC32 protein.

   Evidence Yeast two-hybrid screen of a human monocyte cDNA library against an annexin A2 C-terminal fragment

   PMID:21963895

   Open questions at the time

   • Single yeast two-hybrid result not confirmed by an orthogonal method
   • No functional follow-up linking this interaction to a cellular role
   • Relationship of this interaction to the later-established endocytic function is unestablished
2. 2020 Medium

   The question of what physiological process CCDC32 supports was first answered by showing it is required for cilia formation, connecting the gene to a congenital syndrome.

   Evidence Zebrafish morpholino knockdown with cilia readout plus mammalian cell loss-of-function

   PMID:32307552

   Open questions at the time

   • Molecular mechanism by which CCDC32 supports ciliogenesis not defined
   • Relationship between the ciliary role and endocytic role not resolved
   • Morpholino-based knockdown not corroborated by genetic deletion
3. 2021 Medium

   An unbiased genetic approach placed CCDC32 in the endocytic machinery, establishing AP-2 binding and a functional requirement for cargo uptake.

   Evidence Co-essentiality profiling validated by transferrin uptake assay and localization to clathrin-coated pits

   PMID:33859415

   Open questions at the time

   • Did not define which AP-2 subunits or domains are contacted
   • Mechanism of action within the coated pit not addressed
   • Single lab, correlative localization
4. 2024 High

   Reconstitution revealed CCDC32's mechanism as an AP-2 assembly chaperone acting downstream of AAGAB, explaining how disease mutations impair function.

   Evidence Biochemical reconstitution, co-immunoprecipitation, in vitro assembly assays, and disease-variant mutagenesis

   PMID:39145939

   Open questions at the time

   • Structural basis of the ternary template not resolved at this stage
   • Trigger for CCDC32 release after assembly not defined
   • Link to the ciliary phenotype not addressed
5. 2025 High

   Cell-based and structural studies mapped the AP-2 binding interfaces and showed CCDC32 stabilizes coated pits, while defining a PIP2-gated inhibitory mechanism.

   Evidence siRNA knockdown with live imaging, deletion mutagenesis, in vitro binding, cryo-EM, and PIP2-membrane and AP-2 disassembly assays

   PMID:38979322 PMID:40799577 PMID:41489497 PMID:42234739

   Open questions at the time

   • How the membrane switch is coordinated with cargo loading in vivo not fully defined
   • Whether the cargo sorting motifs in CCDC32 engage physiological cargo unresolved
   • Quantitative kinetics of inhibition relief at native plasma membranes not established

• Whether CCDC32's ciliary requirement reflects its AP-2 chaperone activity or a distinct molecular function remains unresolved.
• No mechanistic bridge between AP-2 assembly and ciliogenesis
• No structural model of CCDC32 outside the AP-2-bound state
• Tissue-specific requirements underlying the syndrome not defined